CIDRAP newsletters options
(CIDRAP News) The immunization advisory group for the US Centers for Disease Control and Prevention (CDC) meets tomorrow in an emergency session to discuss which groups should be targeted to receive the pandemic H1N1 vaccine and whether some should have priority.
Pregnant women bear disproportionate share of flu deaths
Europe plans to streamline H1N1 flu vaccine approval
GAO criticizes choice of Kansas for animal disease lab, report saysA draft report from the Government Accountability Office (GAO) says the Department of Homeland Security (DHS) used a flawed analysis in deciding to locate a special animal disease laboratory in Manhattan, Kan., the Washington Post reported today. The GAO said DHS greatly underestimated the risk of an accidental release of dangerous pathogens from the lab, as the site is in a tornado-prone area.
(CIDRAP News) Pandemic H1N1 influenza activity decreased for the fourth consecutive week, though the percentage of deaths from pneumonia and influenza rose a bit above the epidemic threshold, the US Centers for Disease Control and Prevention (CDC) said today.
Jul 24, 2009
I bet most of you never thought that your workplace would demand the tools of the military battlefield, including the concept of anticipated casualties, to prepare for an inevitable microbial attack. Well, I'm convinced you will.
Jul 23, 2009
(CIDRAP News) - The World Health Organization (WHO) recently posted surveillance and status updates for regions where the pandemic H1N1 is just gaining a foothold, including the Mideast, Africa, and parts of Asia and the Pacific, which showed Southeast Asia as the hardest hit of those areas.
(CIDRAP News) The Food and Drug Administration (FDA) may review vaccines for the novel H1N1 influenza virus the same way it evaluates the annual updates of seasonal flu vaccines, which would probably lead to faster FDA approval than occurs with brand-new products, an FDA official said in the wake of an FDA advisory committee meeting today.
Jul 22, 2009
(CIDRAP News) Federal health officials today announced plans to launch several clinical trials of pandemic H1N1 vaccines in a race to gather safety and immunogenicity data in time for a possible fall resurgence of the novel virus. In some of the trials, volunteers will receive H1N1 and seasonal flu shots at the same time.
(CIDRAP News) The Food and Drug Administration (FDA) yesterday announced its approval of seasonal influenza vaccines for this year, the annual step that clears the way for manufacturers to start marketing their vaccines.
NIAID to study simultaneous seasonal-flu, pandemic vaccination
(CIDRAP News) Federal health officials are proposing to list the virus that causes SARS (severe acute respiratory syndrome) as a select agent, which means that dozens of laboratories possessing it will have to register with the government and adopt various security measures.
(CIDRAP News) An expert panel that advises the Department of Health and Human Services (HHS) today supported the idea of moving quickly on pandemic H1N1 vaccine production with a goal of having "tens of millions of doses" available in September instead of October.
Jul 17 2009 (CIDRAP News) Novel flu activity is still going strong but dropped for the third week in a row, the US Centers for Disease Control and Prevention (CDC) said today during a media briefing that also sought to calm fears about vaccine availability.
Jul 16, 2009
(CIDRAP News) Citing the questionable usefulness of reporting pandemic H1N1 case counts and the burden it puts on countries experiencing widespread transmission, the World Health Organization (WHO) announced today it will no longer issue regular reports of confirmed global case totals.
The WHO has issued 58 such reports since the start of the novel H1N1 outbreak, the last one on Jul 6.
American Lung Association recommends closing affiliated summer camps